Igor D. Bandeira 
Happy to share that I have been selected for the Alies Muskin Career Development Leadership Award from the Anxiety and Depression Association of America (ADAA)! #ADAA2025
Our study explores innovative strategies to prolong the antisuicidal effects of ketamine in individuals with treatment-resistant depression, a critical step toward improving outcomes for patients in crisis.
This recognition not only supports early-career researchers like myself, but also strengthens our collective mission to advance evidence-based care for depression and suicidality.
#ADAA2025 #SuicidePrevention #DepressionResearch #CareerDevelopment #ClinicalTrials #MentalHealthResearch